Association of drug susceptibility testing results for first- and second-line drugs with treatment outcomes in patients with multidrug-resistant and extensively drug-resistant tuberculosis

Affiliations

¹ Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University.
² Department of Respiratory Medicine, Zhengzhou Central Hospital, Zhengzhou University, Henan Province, People's Republic of China.

Comment

Wang Hong-min et al. Clin Infect Dis. 2015.

. 2015 Apr 15;60(8):1285-6.

doi: 10.1093/cid/ciu1169. Epub 2014 Dec 30.

¹ Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University.
² Department of Respiratory Medicine, Zhengzhou Central Hospital, Zhengzhou University, Henan Province, People's Republic of China.

No abstract available

Comment in

Reply to Wang and Zhang.
Bastos ML, Menzies D; Collaborative Group for Meta-analysis of Individual Patient Data in Multidrug-Resistant Tuberculosis. Bastos ML, et al. Clin Infect Dis. 2015 Apr 15;60(8):1286-7. doi: 10.1093/cid/ciu1171. Epub 2014 Dec 30. Clin Infect Dis. 2015. PMID: 25552550 No abstract available.

Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.
Bastos ML, Hussain H, Weyer K, Garcia-Garcia L, Leimane V, Leung CC, Narita M, Penã JM, Ponce-de-Leon A, Seung KJ, Shean K, Sifuentes-Osornio J, Van der Walt M, Van der Werf TS, Yew WW, Menzies D; Collaborative Group for Meta-analysis of Individual Patient Data in MDR-TB. Bastos ML, et al. Clin Infect Dis. 2014 Nov 15;59(10):1364-74. doi: 10.1093/cid/ciu619. Epub 2014 Aug 5. Clin Infect Dis. 2014. PMID: 25097082 Free PMC article.